InvestorsHub Logo
Followers 26
Posts 665
Boards Moderated 0
Alias Born 04/30/2019

Re: None

Saturday, 08/17/2019 3:38:59 PM

Saturday, August 17, 2019 3:38:59 PM

Post# of 424788
Update: CADTH, which parallels Health Canada to review drugs/set reimbursement rates, has temporarily suspended review of Vascepa pending receipt/review of info. Could be FDA Adcom related or related to label (were evaluating "elevated" TGs) or both.

From TerraPharma

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News